MedPath

Acetylcysteine

Generic Name
Acetylcysteine
Brand Names
Acetadote
Drug Type
Small Molecule
Chemical Formula
C5H9NO3S
CAS Number
616-91-1
Unique Ingredient Identifier
WYQ7N0BPYC

Overview

Acetylcysteine is an antioxidant and glutathione inducer indicated for mucolytic therapy and the treatment of acetaminophen overdose. Acetylcysteine has also been studied for a wide variety of off-label indications with mixed results. Acetylcysteine was granted FDA approval on 14 September 1963.

Background

Acetylcysteine is an antioxidant and glutathione inducer indicated for mucolytic therapy and the treatment of acetaminophen overdose. Acetylcysteine has also been studied for a wide variety of off-label indications with mixed results. Acetylcysteine was granted FDA approval on 14 September 1963.

Indication

Acetylcysteine is indicated for mucolytic therapy and in the management of acetaminophen overdose.

Associated Conditions

  • Acetaminophen Overdose
  • Chronic Rhinitis
  • Corneal Diseases
  • Corneal ulceration
  • Crusting Rhinitis
  • Keratopathy
  • Rhinitis
  • Sinusitis
  • Vasomotor Rhinitis
  • Acute Rhinitis
  • Subacute Rhinitis

FDA Approved Products

Acetylcysteine
Manufacturer:American Regent, Inc.
Route:RESPIRATORY (INHALATION)
Strength:200 mg in 1 mL
Approved: 2019/08/21
NDC:0517-7604
Acetylcysteine
Manufacturer:Cardinal Health 107, LLC
Route:RESPIRATORY (INHALATION), ORAL
Strength:100 mg in 1 mL
Approved: 2017/06/13
NDC:55154-5730
Acetylcysteine
Manufacturer:Cardinal Health 107, LLC
Route:RESPIRATORY (INHALATION), ORAL
Strength:200 mg in 1 mL
Approved: 2017/06/13
NDC:55154-5731
Acetylcysteine
Manufacturer:Sagent Pharmaceuticals
Route:INTRAVENOUS
Strength:200 mg in 1 mL
Approved: 2022/04/05
NDC:25021-812
Acetylcysteine
Manufacturer:Fresenius Kabi USA, LLC
Route:ORAL, RESPIRATORY (INHALATION)
Strength:200 mg in 1 mL
Approved: 2019/07/02
NDC:63323-690

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath